Hi Neptune, If you go back to January you will see that there were a number of discussions over the potential tax liability of CSE on its SYR shares. In last years annual report CSE revalued SYR shares to $2.33 and recognised the tax payable on that gain. Due to accrued losses there would be no tax payable. On this basis with SYR currently at $1.74 there is still no tax potentially payable on any sale.
So, this leads to the following calculation...
106.845m shares on issue - no oppies so no further dilution.
Cash as of 31 Mar 13 = $2.23m (with estimate of $200k outflow for the current quarter to 30 June)
SYR shares held = 11 million
Value = 11m x $1.74 = $19.14m
Tax already accounted for in 2012 for SYR valuation at $25.63m (see page 45 of AR). Therefore no additional tax to be recognised.
So profit net of tax is $19.14m. Add in cash estimate 30 June $2.0m = $21.14m
$21.14m/106.845 = 19.8 cents per share.
With CSE last trade at 12.5 cents this is a 58% undervaluation.
- Forums
- ASX - By Stock
- CSE
- interesting valuation
interesting valuation, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSE (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.80M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CSE (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online